Detail Information of Xenobiotics
| General Information of Xenobiotics (ID: XEO00513) | ||||||
|---|---|---|---|---|---|---|
| Xenobiotics Name |
Acenocoumarol
|
|||||
| Xenobiotics Type |
Pharmaceutical Agent(s)
|
|||||
| Classification |
Approved/Marketed Drug
|
|||||
| Structure |
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=54676537"></iframe>
|
 |
||||
| 3D MOL | 2D MOL | |||||
| PubChem CID | ||||||
| DME(s) Modulated by This Xenobiotics | ||||||
| DME(s) Inhibited by This Xenobiotics | ||||||
| Vitamin K1 2,3-epoxide reductase 1 (VKOR) | DME Info | Homo sapiens | [1] | |||
| VKORC1-like protein 1 (VKORC1L1) | DME Info | Homo sapiens | [1] | |||
| References | ||||||
| 1 | VKORC1 and VKORC1L1 have distinctly different oral anticoagulant dose-response characteristics and binding sites. Blood Adv. 2018 Mar 27;2(6):691-702. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.